American College of Obstetricians and Gynecologists

Short answer: choose a clinic run by board‑certified physicians who practice evidence‑based hormone medicine, require baseline labs and routine safety monitoring, prefer FDA‑approved preparations when appropriate, and will document individualized goals and follow‑up. Avoid clinics that push treatment after an online quiz, rely on saliva tests alone, or sell “one‑size‑fits‑all” compounded creams without lab follow‑up. Concrete checklist to vet a BHRT clinic Clinician credentials Are the prescribers board‑certified in endocrinology, gynecology, family medicine or internal medicine? Bonus if they are a NAMS Certified Menopause Practitioner (NCMP) or REI/endocrinology fellowship trained. Verify on the state medical board or American Board of Medical Specialties. Evaluation process Do they take a full history and physical exam (or video visit) rather than only an online quiz? Do they order baseline labs and imaging as indicated (notably labs appropriate to your sex/age and symptom set)? Testing standards They should use reputable labs (Quest, LabCorp, hospital labs). Be cautious if the clinic relies primarily on saliva testing or an online questionnaire as the basis for long‑term prescriptions. Treatment approach Prefer FDA‑approved hormone formulations when available (patches, pills, gels, injections) unless there is a clear reason to use a compound. If compounding is necessary, the pharmacy should follow USP standards (sterile/nonsterile compounding per USP) and be willing to provide Certificates of Analysis (CoA) or evidence of accreditation. Safety monitoring and follow‑up Ask how often they re‑check labs and adjust doses, and how they monitor risks (mammography, bone density, hematocrit/PSA for men on testosterone, liver function, lipid panel, etc.). There should be a written plan for stopping or tapering treatment and for managing side effects. Cost transparency and prescribing practices Clear pricing, explanation of what is compounded vs FDA‑approved, and no high‑pressure auto‑refill/subscription upsells. Red flags No baseline labs or follow‑up, prescribing after a short online quiz only, strong anti‑medicine buzzwords (“detox,” “optimum level for everyone,” “age reversal”), aggressive promotion of unvalidated tests, secret proprietary “hormone optimization” ranges, refusal to discuss risks. Typical tests you should expect (general, not medical advice — will vary by sex/age/symptoms) For women: estradiol, FSH, LH (if relevant), progesterone (when indicated), thyroid tests (TSH ± free T4), CBC, CMP (liver/kidney), lipid panel, and age‑appropriate mammography/bone density screening. For men: total testosterone (morning sample), free testosterone or calculated free when indicated, SHBG, CBC (hematocrit), PSA (when appropriate), CMP, lipid panel. Some clinicians may add cortisol, DHEA, or urinary steroid profiles (DUTCH) in specific situations; these have niche uses and should not replace serum testing unless the clinician explains why. Organizations and reputable places to consider Professional societies for vetting providers: North American Menopause Society (NAMS) — “Find a Menopause Practitioner,” Endocrine Society, American College of Obstetricians and Gynecologists (ACOG). Large academic centers with menopause/endocrine expertise: Mayo Clinic, Cleveland Clinic, Johns Hopkins, UCSF — these centers have multidisciplinary menopause and endocrine clinics and follow evidence‑based protocols. Reputable labs: Quest Diagnostics, LabCorp, major hospital labs. Compounding pharmacy standard to ask for: compliance with USP 795/797/800 standards and willingness to provide a Certificate of Analysis for compounded products. Names to look for (examples) Clinics: Mayo Clinic Menopause Clinic, Cleveland Clinic Women’s Health — good choices if you want conservative, evidence‑based care from academic centers. Directories: Search NAMS “Find a Practitioner” or check state medical board listings for board‑certified endocrinologists/gynecologists. (If you’d like telemedicine, I can help find telehealth clinicians affiliated with academic centers or vetted practitioners in your state—telehealth companies vary widely in quality.) What to say when you contact a clinic (quick script) “Are your prescribers board‑certified? Do you require baseline labs before prescribing hormones, and which labs? How do you monitor safety and how often do you follow up? Do you use FDA‑approved hormones or compounded products, and which compounding pharmacies do you use? Can you provide your credentialing and references?” If you want, tell me: whether this is for male or female hormones, your age range, and whether you prefer in‑person or telemedicine care, and I’ll recommend clinics or providers in your area or reputable programs you can contact.

Mentioned in position 5 of 9

Short answer: Bioidentical hormone replacement therapy (BHRT) can be safe and effective for treating menopausal symptoms when prescribed and monitored appropriately — but there’s an important distinction doctors make between FDA‑approved “bioidentical” hormones and unregulated compounded BHRT. Most professional medical societies recommend FDA‑approved products and caution about compounded preparations. Key points doctors and medical organizations say “Bioidentical” simply means the hormone molecule is chemically identical to the human hormone (e.g., 17β‑estradiol, micronized progesterone). That alone doesn’t guarantee safety. FDA‑approved bioidentical hormones (standard prescription products) have documented dosing, quality control, and clinical-trial data on benefits and risks. Clinicians generally prefer these because they are regulated and tested. Compounded BHRT (custom creams, troches, gels made by compounding pharmacies) lacks the same regulation and consistent dosing. Major bodies — North American Menopause Society (NAMS), American College of Obstetricians and Gynecologists (ACOG), the Endocrine Society and the FDA — warn that claims about “customized” or “safer/natural” compounded hormones are not well supported by evidence. Risks of hormone therapy depend on type/dose/route and patient factors (age, time since menopause, medical history). Known risks of systemic estrogen (especially combined estrogen–progestin) include increased risk of blood clots, stroke, and, with long‑term use, possible increased breast cancer risk. Transdermal estrogen may have lower clot risk than oral estrogen; micronized progesterone may have a more favorable profile than some synthetic progestins. Saliva hormone testing (often marketed by BHRT clinics) is unreliable for guiding dosing; most doctors do not use it for management. Practical, doctor‑oriented guidance If you and your clinician decide on hormone therapy, prefer FDA‑approved, regulated products when possible (predictable dosing, safety data). Use the lowest effective dose for symptoms and reassess regularly. If you have a uterus and are taking systemic estrogen, you need an appropriate progestogen to protect the endometrium. Discuss personal risk factors (breast cancer history, clotting disorders, cardiovascular disease, liver disease, smoking) before starting. Get regular follow‑up: symptom review, screening (mammography), and labs guided by your clinician. Specific FDA‑approved products doctors commonly use (examples) Estradiol (oral/transdermal/vaginal): Estrace (oral), Climara / Estraderm / Vivelle‑Dot / Alora (patches), Vagifem (vaginal tablet), Estring (vaginal ring) Micronized progesterone: Prometrium (oral); Crinone, Endometrin (vaginal progesterone preparations) Combination product: Bijuva (oral estradiol + progesterone capsule) Testosterone (for men: AndroGel, Testim, Androderm — for women, testosterone therapy is off‑label and used cautiously with limited evidence) If you’re considering compounded BHRT Be cautious. Ask the prescriber why a compounded product is needed instead of an FDA‑approved product. If you still choose compounding, use a pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) or one with strong quality control, and request certificates of analysis and USP compliance. Expect close follow‑up and objective clinical endpoints (symptoms, safety monitoring) rather than saliva tests. Trusted resources and organizations North American Menopause Society (NAMS) — position statements and patient info American College of Obstetricians and Gynecologists (ACOG) The Endocrine Society FDA consumer information on BHRT and compounded hormones Major medical centers: Mayo Clinic, Cleveland Clinic (reliable patient guides) Bottom line BHRT can be a safe, effective option if you use evidence‑based, FDA‑approved hormones under a clinician’s supervision and with appropriate monitoring. Be skeptical of claims that compounded BHRT is inherently safer or more “natural,” and avoid saliva testing as a dosing guide. Talk with a gynecologist, endocrinologist, or a menopause specialist about which option fits your symptoms and risks. If you’d like, tell me your age, symptoms, medical history (e.g., history of clotting, breast cancer, heart disease), and whether you’re already on any hormones — I can help summarize the pros and cons for your situation and suggest questions to ask a clinician.

Mentioned in position 17 of 19

Short version — look for board-certified specialists who use evidence-based testing, explain risks and alternatives, use FDA-approved products when appropriate, and follow you with labs and symptoms. Avoid clinics that sell “one-size-fits-all” pellets or prescribe from a checkbox visit without labs or ongoing follow-up. Concrete checklist (what to require) Provider credentials: board-certified (endocrinologist, gynecologist, urologist, or family physician with relevant board certification). Verify on ABMS (American Board of Medical Specialties). Specialty experience: menopause or hormone-management experience; preferably a North American Menopause Society (NAMS) Certified Menopause Practitioner (NCMP). Evidence-based testing: baseline and follow-up labs (serum tests for most systemic hormones). Be wary of clinics that rely only on saliva tests. Informed consent and risk discussion: documented discussion of benefits, risks (breast, clotting, CV, liver, acne, mood, fertility impacts), and alternatives. Individualized dosing plus scheduled follow-up and lab monitoring (not just a one-time Rx or implants placed with no follow-up). Pharmacy transparency: if they use compounded hormones, the pharmacy should be accredited (PCAB/ACHC) and willing to provide quality-control documentation. Prefer FDA‑approved formulations when available. Clear pricing and written plan for starting, adjusting, and stopping therapy. Questions to ask a prospective clinic Are you board-certified in (specialty)? Can I see your credentials? Do you follow evidence-based guidelines? Which guidelines do you use? What tests do you order before prescribing? How often will you monitor me? Do you use saliva tests, urine DUTCH, or serum blood tests — and why? Do you prescribe FDA‑approved hormone products first, or go straight to compounded bioidentical hormones? Which compounding pharmacy do you use and is it accredited? What are the expected benefits and the risks for my age/health profile? How long before we reassess? Red flags (avoid clinics that:) Prescribe hormones after a 10–15 minute visit or only an online questionnaire. Rely exclusively on saliva testing for systemic hormone replacement. Use “hormone pellet” implants as the only or default treatment without detailed evaluation and monitoring. Promise dramatic anti‑aging effects or “cure” claims. Sell the hormones directly with pressure to purchase on site. Provide no written consent or follow-up testing plan. Specific organizations and services to consider (and why) Mayo Clinic, Cleveland Clinic, Johns Hopkins — large academic centers; multidisciplinary, evidence-based care and easy ways to verify clinician credentials. Good if you want a conservative, guideline-driven approach. North American Menopause Society (NAMS) — use their “Find a Provider” tool to locate NAMS‑qualified clinicians (NCMP) who specialize in menopause care. NAMS also publishes position statements and guidance. Endocrine Society / American College of Obstetricians and Gynecologists (ACOG) — professional guidelines and patient resources that reflect current evidence. Ask clinics whether they follow these guidelines. Quest Diagnostics or LabCorp — commonly used, reliable labs for standard serum hormone testing. Precision Analytical (DUTCH test) — a well-known specialized urinary steroid metabolite test; it can be useful in specialized situations but should be interpreted by a clinician familiar with its limitations. Look for compounding pharmacies accredited by PCAB/ACHC (ask the clinic which pharmacy they use and verify). If an FDA‑approved product exists for your indication, prefer it (examples of FDA‑approved formulations include estradiol patches like Climara or Vivelle‑Dot, oral estradiol Estrace, and micronized progesterone Prometrium). Practical next steps Start with a local academic menopause or women’s health clinic or use NAMS to find an NCMP. Verify the clinician’s board certification (ABMS) and ask about their experience with BHRT. Ask for a copy of the clinic’s evaluation protocol (what labs, imaging, follow-up intervals). If a clinic recommends compounded hormones, ask which pharmacy and check its accreditation and testing procedures. Get everything in writing (treatment plan, monitoring schedule, stop criteria, costs). If you want, tell me your city or zip code and whether you’re looking for in‑person or telehealth care; I can suggest local clinics or vetted telemedicine services and help you prepare a short list of questions to bring to the appointment.

Mentioned in position 6 of 13

Short answer “Bioidentical” simply means the hormone molecule is chemically identical to the hormone your body makes (for example, estradiol or micronized progesterone). Some bioidentical products are FDA‑approved prescription drugs; others are custom‑made (“compounded”) by pharmacies and are not FDA‑tested. Many doctors say FDA‑approved bioidentical hormone therapies can be safe and effective for appropriate patients when prescribed, dosed and monitored correctly. Most professional societies warn against unproven claims about compounded BHRT and recommend using FDA‑approved products whenever possible. What the evidence and major medical groups say For bothersome menopausal symptoms (hot flashes, night sweats, vaginal dryness) hormone therapy is the most effective treatment. Benefits and risks depend on the type of hormone, dose, route (oral vs transdermal vs vaginal), whether a progestogen is needed, your age, and your medical history. The Women’s Health Initiative (WHI) raised important safety concerns (increased risk of blood clots, stroke and, with combined therapy, a small increase in breast cancer). Later analyses clarified that risk varies: starting HT nearer to menopause and using lower doses tends to carry lower cardiovascular risk. Transdermal estradiol (patch/gel) and oral micronized progesterone appear to have lower venous thromboembolism risk than some oral estrogens or synthetic progestins. Vaginal low‑dose estrogen is effective for local urogenital symptoms with minimal systemic exposure. Major organizations (North American Menopause Society, Endocrine Society, American College of Obstetricians & Gynecologists) advise: use FDA‑approved products when possible, do individualized risk/benefit discussions, avoid marketing claims that compounded BHRT is safer or superior without evidence. Compounded BHRT: the concerns Compounded hormones are made by pharmacies to individual prescriptions and are not evaluated/approved by the FDA. Concerns include inconsistent dosing, purity, lack of clinical trials proving safety/effectiveness, and sometimes marketing that misleads patients (eg, “natural” = safer). That doesn’t mean compounding is never appropriate, but it should be used only when an FDA‑approved option truly won’t meet the patient’s needs and under careful supervision. Practical guidance — what to ask your doctor Do I actually need hormone therapy for my symptoms? What are the expected benefits? Which formulation (oral, patch, gel, vaginal) and which hormone do you recommend, and why? Can we use an FDA‑approved product? What are my individualized risks (clotting, heart disease, stroke, breast cancer)? How will we monitor? If you propose compounded BHRT, why is it necessary and what evidence supports it for my situation? Examples of FDA‑approved products (commonly used, bioidentical hormones) Estradiol patches/gels: Climara, Vivelle‑Dot, Alora (transdermal estradiol) — useful when avoiding first‑pass liver effects and may carry lower clot risk. Oral estradiol: Estrace (oral estradiol) — an FDA‑approved form of bioidentical estradiol. Micronized progesterone: Prometrium — FDA‑approved bioidentical progesterone used when a progestogen is required for women with a uterus. Vaginal/local products for urogenital symptoms: Vagifem (vaginal estradiol tablet), Estring (vaginal ring), Estrace cream — low systemic absorption for local symptoms. Trusted sources and services North American Menopause Society (NAMS) — evidence‑based guidelines and a clinician directory. Endocrine Society and American College of Obstetricians & Gynecologists (ACOG) — clinical practice guidelines. Reputable academic clinics (Mayo Clinic, Cleveland Clinic, major university women’s health/menopause clinics) for second opinions or complex cases. When BHRT might be appropriate Short‑term treatment for moderate–severe menopausal vasomotor symptoms in healthy women, especially those who are younger (<60) or within about 10 years of menopause, is a common and accepted indication when individualized. Vaginal estrogens are appropriate for bothersome local symptoms at any age in many cases. Testosterone for low libido in women is sometimes considered off‑label in specialized care, but it isn’t broadly FDA‑approved for women. When to be cautious Personal or strong family history of breast cancer, active liver disease, unexplained vaginal bleeding, or a history of venous thromboembolism typically prompt avoidance or extra caution and specialist consultation. Bottom line BHRT can be safe and effective when it’s an FDA‑approved product prescribed after a careful, individualized discussion of risks and benefits and with appropriate follow‑up. Be skeptical of broad “natural” safety claims for compounded BHRT; if your clinician recommends compounded products, ask why an FDA‑approved option won’t work and what monitoring will be done. If you’d like, tell me a bit about your age, symptoms and medical history and I can outline options you can discuss with your clinician.

Mentioned in position 10 of 10